The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
854
October 4, 1991
View Complete Issue         Table of Contents 2019 
FK 506 - An Investigational Immunosuppressant
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
FK 506 - An Investigational Immunosuppressant
October 4, 1991 (Issue: 854)
FK 506 (Fujisawa), an immunosuppressant similar in activity to cyclosporine (Sandimmune - Medical Letter 25:77, 1983), is currently under investigation in the USA, Europe, and Japan for prevention of organ transplant rejection.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: FK 506 - An Investigational Immunosuppressant
Article code: 854c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.